Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/213599
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Inflammatory cytokines shape a changing DNA methylome in monocytes mirroring disease activity in rheumatoid arthritis |
Autor: | Rodríguez-Ubreva, Javier; Calle-Fabregat, Carlos de la; Li, T.; Ciudad, Laura CSIC ORCID; Ballestar, M.L.; Català-Moll, Francesc; Morante-Palacios, O.; García-Gómez, Antonio; Celis, Rafael CSIC ORCID ; Humby, F.; Nerviani, A.; Martín, J.; Pitzalis, C.; Cañete, J.D.; Ballestar, Estéban | Palabras clave: | DAS28 DNA methylation TNFa disease activity rheumatoid arthritis |
Fecha de publicación: | 2019 | Editor: | BMJ Publishing Group | Citación: | Annals of the Rheumatic Diseases (2019) | Resumen: | Objective: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that mainly targets joints. Monocytes and macrophages are critical in RA pathogenesis and contribute to inflammatory lesions. These extremely plastic cells respond to extracellular signals which cause epigenomic changes that define their pathogenic phenotype. Here, we interrogated how DNA methylation alterations in RA monocytes are determined by extracellular signals. Methods: High-throughput DNA methylation analyses of patients with RA and controls and in vitro cytokine stimulation were used to investigate the underlying mechanisms behind DNA methylation alterations in RA as well as their relationship with clinical parameters, including RA disease activity. Results: The DNA methylomes of peripheral blood monocytes displayed significant changes and increased variability in patients with RA with respect to healthy controls. Changes in the monocyte methylome correlate with DAS28, in which high-activity patients are divergent from healthy controls in contrast to remission patients whose methylome is virtually identical to healthy controls. Indeed, the notion of a changing monocyte methylome is supported after comparing the profiles of same individuals at different stages of activity. We show how these changes are mediated by an increase in disease activity-associated cytokines, such as tumour necrosis factor alpha and interferons, as they recapitulate the DNA methylation changes observed in patients in vitro. Conclusion: We demonstrate a direct link between RA disease activity and the monocyte methylome through the action of inflammation-associated cytokines. Finally, we have obtained a DNA methylation-based mathematical formula that predicts inflammation-mediated disease activity for RA and other chronic immune-mediated inflammatory diseases. | Versión del editor: | http://dx.doi.org/10.1136/annrheumdis-2019-215355 | URI: | http://hdl.handle.net/10261/213599 | DOI: | 10.1136/annrheumdis-2019-215355 | Identificadores: | doi: 10.1136/annrheumdis-2019-215355 issn: 1468-2060 |
Aparece en las colecciones: | (IPBLN) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
44
checked on 19-abr-2024
WEB OF SCIENCETM
Citations
41
checked on 26-feb-2024
Page view(s)
166
checked on 23-abr-2024
Download(s)
37
checked on 23-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.